Lv41
470 积分 2025-02-23 加入
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
13天前
已完结
Under the Hood: Evidence-Based Review of Allogeneic Chimeric Antigen Receptor T Cells for Hematologic Malignancies
13天前
已关闭
Hypoimmunogenic pluripotent stem cells: A game-changer in cell-based regenerative medicine
16天前
已完结
BCMA-targeted CAR T cell therapy can effectively induce disease remission in refractory lupus nephritis
20天前
已完结
CAR-T cell targeting three receptors on autoreactive B cells for systemic lupus erythematosus therapy
20天前
已完结
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis
20天前
已完结
CAR T-cell therapy induces remission in multiorgan IgG4-related disease with hepatobiliary involvement
21天前
已完结
Approaching the holy grail in autoimmunity: CD19 CAR T-cell therapy in multiorgan IgG4-related disease
21天前
已完结
CAR T-cell therapy induces remission in multiorgan IgG4-related disease with hepatobiliary involvement
21天前
已完结
Efficacy and safety of anti-CD19 CAR-T in a mouse model of IgG4-related disease
21天前
已完结
皖公网安备34019202002308
